Business Segment Information (Tables)

6 Months Ended

Jun. 27, 2015

Business Segments

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information
				Three Months Ended						Six Months Ended
			June 27,			June 28,			June 27,			June 28,
(In millions)				2015			2014			2015			2014
Revenues
	Life Sciences Solutions			$	1,129.3		$	1,103.1		$	2,149.2		$	1,938.6
	Analytical Instruments				777.0			793.4			1,504.4			1,563.3
	Specialty Diagnostics				817.1			855.1			1,602.3			1,668.8
	Laboratory Products and Services				1,693.3			1,699.4			3,206.7			3,289.9
	Eliminations				(145.8)			(129.1)			(272.9)			(235.2)
		Consolidated revenues			4,270.9			4,321.9			8,189.7			8,225.4
Segment Income (a)
	Life Sciences Solutions				323.5			299.1			622.2			543.7
	Analytical Instruments				139.6			130.4			261.3			261.3
	Specialty Diagnostics				227.2			236.4			441.3			457.4
	Laboratory Products and Services				260.0			257.7			482.1			491.7
		Subtotal reportable segments (a)			950.3			923.6			1,806.9			1,754.1
	Cost of revenues charges				(1.1)			(156.1)			(1.7)			(324.6)
	Selling, general and administrative charges, net				(3.2)			(14.9)			(10.8)			(97.7)
	Restructuring and other (costs) income, net				(20.4)			(60.9)			(52.4)			521.3
	Amortization of acquisition-related intangible assets				(329.8)			(343.6)			(658.9)			(629.5)
		Consolidated operating income			595.8			348.1			1,083.1			1,223.6
	Other expense, net (b)				(92.2)			(111.6)			(197.5)			(212.7)
	Income from continuing operations before income taxes			$	503.6		$	236.5		$	885.6		$	1,010.9
Depreciation
	Life Sciences Solutions			$	34.8		$	36.3		$	68.3		$	60.3
	Analytical Instruments				9.4			9.2			18.7			19.6
	Specialty Diagnostics				18.0			19.2			35.8			38.0
	Laboratory Products and Services				27.7			26.5			54.3			53.0
		Consolidated depreciation		$	89.9		$	91.2		$	177.1		$	170.9
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information
				Three Months Ended						Six Months Ended
			June 27,			June 28,			June 27,			June 28,
(In millions)				2015			2014			2015			2014
Revenues
	Life Sciences Solutions			$	1,129.3		$	1,103.1		$	2,149.2		$	1,938.6
	Analytical Instruments				777.0			793.4			1,504.4			1,563.3
	Specialty Diagnostics				817.1			855.1			1,602.3			1,668.8
	Laboratory Products and Services				1,693.3			1,699.4			3,206.7			3,289.9
	Eliminations				(145.8)			(129.1)			(272.9)			(235.2)
		Consolidated revenues			4,270.9			4,321.9			8,189.7			8,225.4
Segment Income (a)
	Life Sciences Solutions				323.5			299.1			622.2			543.7
	Analytical Instruments				139.6			130.4			261.3			261.3
	Specialty Diagnostics				227.2			236.4			441.3			457.4
	Laboratory Products and Services				260.0			257.7			482.1			491.7
		Subtotal reportable segments (a)			950.3			923.6			1,806.9			1,754.1
	Cost of revenues charges				(1.1)			(156.1)			(1.7)			(324.6)
	Selling, general and administrative charges, net				(3.2)			(14.9)			(10.8)			(97.7)
	Restructuring and other (costs) income, net				(20.4)			(60.9)			(52.4)			521.3
	Amortization of acquisition-related intangible assets				(329.8)			(343.6)			(658.9)			(629.5)
		Consolidated operating income			595.8			348.1			1,083.1			1,223.6
	Other expense, net (b)				(92.2)			(111.6)			(197.5)			(212.7)
	Income from continuing operations before income taxes			$	503.6		$	236.5		$	885.6		$	1,010.9
Depreciation
	Life Sciences Solutions			$	34.8		$	36.3		$	68.3		$	60.3
	Analytical Instruments				9.4			9.2			18.7			19.6
	Specialty Diagnostics				18.0			19.2			35.8			38.0
	Laboratory Products and Services				27.7			26.5			54.3			53.0
		Consolidated depreciation		$	89.9		$	91.2		$	177.1		$	170.9
(a)	Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)	The company does not allocate other expense, net to its segments.